|Número de publicación||US3620218 A|
|Tipo de publicación||Concesión|
|Fecha de publicación||16 Nov 1971|
|Fecha de presentación||25 Ago 1969|
|Fecha de prioridad||31 Oct 1963|
|Número de publicación||US 3620218 A, US 3620218A, US-A-3620218, US3620218 A, US3620218A|
|Inventores||Edward Emil Schmitt, Rocco Albert Polistina|
|Cesionario original||American Cyanamid Co|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citas de patentes (6), Citada por (205), Clasificaciones (21)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
United States Patent 72] Inventors [21 Appl. No.  Filed  Patented  Assignee  CYLINDRICAL PROSTHETIC DEVICES 0F  .lnt.Cl. .4 ..A6lb 17/11  Field olSearch 128/334. 335.5; 3/D1G. 1
 References Cited UNITED STATES PATENTS 2,127,903 8/1938 Bowen 128/334 2,428,918 10/1947 Miller 128/334 2,676,945 4/1954 Higgins.... 260/783 X 3,155,095 11/1964 Brown 128/334 3,297,033 1/1967 Schmitt et a1 128/3355 3,463,158 8/1969 Schmitt et a1 128/334 Primary Examiner- Dalton L. Truluck Attorney-Samuel Branch Walker ABSTRACT: Polyhydroxyactic ester, also called polyglycolic zg fi g gg g g" acid (PGA), has surgically useful mechanical properties as a a solid prosthesis, such as reinforcing pins. screws, plates, or  U.S.Cl 128/334 R, cylinders. On implantation, in living mammalian tissue, the
3/D1G l polyglycolic acid is absorbed, and replaced by living tissue.
div-WA! 4-4.". afll'u' puma-m2; Ewaawmowunw* 1 CYLINDRICAL PROSTHETIC DEVICES OF POLYGLYCOLIC ACID CROSS-REFERENCES This application is a continuation-in-part of application Ser. No. 608,086, Jan. 9, 1967 now U.S. Pat. No. 3,463,158, Aug. 26, 1969, Polyglycolic acid Prosthetic Devices" and Ser. No. 320,543, filed Oct. 31, 1963 now U.S. Pat. No. 3,297,033, Jan. 10, 1967, Surgical Sutures."
FIELD OF INVENTION This invention relates to absorbable surgical structural elements of polyhydroxyacetic ester hereafter called polyglycolic acid (PGA PRIOR ART The use of submucosal tissue and ribbons therefrom internally is described in such patents as U.S. Pat. No. 2,167,251, Rogers, Surgical Tape of Submucosa Tissue," July 25, 1939, U.S. Pat. No. 2,143,910, Didusch, "Ribbon-Gut and Method of Using the Same," Jan. 17, 1939, and U.S. Pat. No. 2,127,903, Bowen, Tube for Surgical Purposes and Method of Preparing and Using the Same,.Aug. 23, 1938.
U.S. Pat. No. 3,155,095, A. M. Brown Anastomosis Method and Means shows an internal and external absorbable coupling for the joining of vascular vessels.
SUMMARY Definitions in the textiletrades are frequently somewhat ambiguous. For purposes of the present application, certain terms are defined:
A "filament" is a single, long, thin flexible structure of a nonabsorbable or absorbable material. It may be continuous or staple.
Staple is used to designate a group of shorter filaments which are usually twisted together to form a longer continuous thread.
An absorbable filament is one which is absorbed, that is digested or dissolved, in living mammalian tissue.
A threa is a plurality of filaments, either continuous or staple, twisted together.
A strand" is a plurality of filaments or threads twisted, plaited, braided, or laid parallel to form a unit for further construction into a fabric,.or used per se, or a monofilament of such size as to be woven or used independently.
A solid prosthetic device" is a thin solid sheet, or plate, or tube, which may be split, or bar, or nail, or screw, or pin or other solid shape which has inherent mechanical strength in compression, bending and shear to act as a solid discrete surgical reinforcing element, and has at least one dimension greater than 2 millimeters, and which may have a dimension as great as about 200 millimeters, or as required, to fit into or adjacent to and furnish mechanical support and reinforcement to a bone, or bones, or gland, or organ, for support during a healing process.
The size and shape of the prosthetic devices, or protheses, is controlled by usage. For example, in the human body, in the case of a bone fracture, a pin is used to reinforce a bone, and is of such a size as to be a tight driving fit into a central portion of the bone, or a hole drilled into a bone. Such a pin can be from about 1/ 16-inch diameter and 16-inch length for finger bones, or for children, up to 1 1/4-inch diameter and, 6-inch length to reinforce the femur, or thigh bone of large adult humans, or even larger for valuable race-horses or other mammals.
The support may be in part directive of growth, as for example in nerve tissue, which grows slowly, and as a result has regeneration impaired by the more rapid growth of scar tissue which can block the growth of the nerve tissue. With a wraparound sheath of PGA sheet, or a split or solid tube used to support, place, hold and'protect; regeneration of nerve tissue and function is greatly aided. Other factors may inhibit regeneration of nerve tissue or function, but with the exclusion of scar tissue, such other factors may be separately treated. PGA is particularly useful in splicing nerves because PGA is completely dissolved in tissue and leaves minimal or no residual scar tissue from the PGA.
For different purposes and in different types of tissue the rate of absorption may vary but in general an absorbable prosthesis should have as high a portion of its original strength as possible for at least 3 days, and sometimes as much as 15 days or more, and preferably should be completely absorbed by muscular tissue within from 45 to days or more depending on the mass of the cross section. The rate of absorption in other tissues may vary even more.
In common with many biological systems, the requirements are not absolute and the rate of absorption as well as the shonterm strength requirement varies from patient to patient and at different locations within the body, as well as with the thickness of the section of PGA.
ThePGA may be formed as tubes or sheets for surgical repair and may. also be spun as thinfilaments and woven or felted to form absorbable sponges or absorbable gauze, or used in conjunction with other compressive structures as prosthetic devices within the body of a human or animal where it is desirable that the structure have short term strength, but be absorbable. The useful embodiments include tubes, including branched tubes or Tees, for artery, vein or intestinal repair, nerve splicing, tendon splicing, sheets for tying up and supportingdamaged kidney, liver and other intestinal organs, protecting damaged surface areas such as abrasions, particularly major abrasions, or areas where the skin and underlying tissues are damaged or surgically removed.
The medical uses of PGA include, but are not necessarily limited to:
A. Pure PGA 1. Solid Products, molded or machined a. Orthopedic pins, clamps, screws and plates b. Clips (e.g., for vena cava) c. Staples d. Hooks, buttons and snaps e. Bone substitute (e.g., mandible prosthesis) f. Needles g. Nonpermanent intrauterine devices (antispermocide) h. Temporary draining or testing tubes or capillaries i. Surgical instruments j. Vascular implants or supports k. Vertebral discs I. Extracorporeal tubing for kidney and heart-lung machines Fibrillar Products, knitted or woven, including velours a. Burn dressings b. Hernia patches c. Absorbent paper or swabs d. Medicated dressings e. Facial substitutes f. Gauze, fabric, sheet, felt or sponge for liver hemostasis g. Gauze bandages h. Dental packs Miscellaneous a. Flake or powder for burns or abrasions b. Foam as absorbable prosthesis c. Substitute for wire in fixations d. Film spray for prosthetic devices B. PGA in Combination with other Products b 1. Solid Products, molded or machined a. Slowly digestible ion-exchange resin b. Slowly digestible drug release device (pill, pellet) c. Reinforced bone pins, needles, etc. 2. Fibrillar Products a. Arterial graft or substitutes b. Bandages for skin surfaces c. Burn dressings (in combination with other polymeric The synthetic character and hence predictable forrnability and consistency in characteristics obtainable from a controlled process are highly desirable.
The most convenient method of sterilizing PGA prostheses is by heat under such conditions that any micro-organisms or deleterious materials are rendered inactive. A second common method is to sterilize using a gaseous sterilizing agent such as ethylene oxide. Other methods of sterilizing include radiation by X-rays, gamma rays, neutrons, electrons, etc., or high-intensity ultrasonic vibrational energy or combinations of these methods. The present materials have such physical characteristics that they may be sterilized by any of these methods.
PGA can be considered as essentially a product of polymerization of glycolic acid, that is hydroxyacetic acid, which in simplified form is shown by the equation:
polyhydroxyaeetlc ester (PGA) g hydroxyacetie acld the cyclic dimeric condensation product formed by dehydrating hydroxyacetic acid. During polymerization of glycolide, the ring is broken and straight-chain polymerization occurs.
Small quantities of other materials may be present in the chain, as for example, d,l-lactic acid, its optically active forms, homologs, and analogs. In general plasticizers tend to interfere with crystallinity, orientation, etc. and weaken the prosthesis but are useful for sponges and films. Other substances may be present, such as dyes, antibiotics, antiseptics, anaesthetics, and antioxidants. Surfaces can be coated with a silicone, beeswax, and the like to modify handling or absorption rate.
The polymerization of glycolide occurs by heating with or without a catalyst, or may be induced by radiation such as X- rays, gamma rays, electron beams, etc. Polymers may also be obtained by condensing glycolic acid or chloraacetic acid with or without a catalyst under a variety of conditions. Good moldable objects or fibers are most readily obtained when the melt viscosity at 245 C. is about 400 to about 27,000 poises.
Polyhydroxyacetic esters have been described in U.S. Pat. No. 2,668,162, Lowe, Preparation of High Molecular Weight Polyhydroxyacetic Ester," and U.S. Pat. No. 2,676,945, Higgins, Condensation Polymers of l-lydroxyacetic Acid."
The processes described in the above two patents can be used for producing PGA from which prostheses may be made. Additives such as triphenylphosphite or Santo-Nox, a disulfide aromatic phenol, can be added as color stabilizers.
DRAWINGS FIG. 1 shows a spliced artery having an internal sleeve with slightly tapered ends, with a sewn splice.
FIG. 2 is a cross section of a spliced artery having an internal sleeve with expanded ends.
FIG. 3 shows a prosthetic sleeve formed of a unitary coupling of solid polyglycolic acid with slightly expanding ends to aid in holding a blood vessel about the sleeve.
FIG. 4, shows the sleeve of FIG. 12 in use in which an external spring clip of solid polyglycolic acid holds the ends of the blood vessel together.
FIG. 5 shows the sleeve of FIG. 12 in which two expandable annular clips are used to hold the ends of the blood vessel approximated.
PGA for the construction of the prostheses shown in the drawings can be produced as set forth in the following examples, in which parts are by weight, unless otherwise clearly indicated.
EXAMPLE 1 One hundred parts of recrystallized glycolide (melting point 85.0 to 85.5" C.) are intimately mixed with 0.02 part of methoxyacetic acid, 0.03 part of phenoldisulfide (Santo-Nox), and 0.03 part antimony trifluoride. Separate glass tubes are each charged with approximately 20 grams of the mixture, deoxygenated by repeated evacuation and argon purging, then sealed under vacuum and heated to 185 to I C. for 4 v1 hours. On cooling a white opaque tough PGA is produced in a 97.5 percent yield with a melt viscosity at 245 C. of 5,000 poises. The polymer is reheated and spun into filaments at a temperature of about 230 C. at a speed of about feet per minute. The filaments produced are cooled, then drawn at about 55 C. When drawn to 5 times the original length a strong tough filament is produced. The dry filaments are in condition for use.
EXAMPLE 2 The polymer of the preceding example is formed into a plurality of smaller filaments, seven of which are twisted into a polyfilamentary strand, which is sterilized and used following the techniques of examples 1.
Because it is a synthetic polymer the methods of forming are more versatile than in starting with naturally occurring materials.
EXAMPLE 3 lnto a suitable reaction vessel there is charged 400 parts of a commercial glycolic acid which is then heated from room temperature to about 200 C. over a period of about 4 hours. When the pot temperature has reached l85 C., the pressure of the system is reduced from atmospheric pressure to 15 mm. of Hg, causing the water of condensation and/or esterification to distill off. The residue is allowed to cool and is pulverized into about 280 parts of a powder which is then added in small increments to a suitable pyrolysis chamber maintained at a temperature of about 250-285 C. at a pressure of less than 15 mm. of Hg. The distillate which weighed about 238 parts is dissolved in a minimum amount of hot ethyl acetate, and after decolorizing and purifying with active carbon, the distillate is recrystallized from the above solution to provide parts of product having a melting point of about 82.5-84.0 C. The infrared spectrum confirms that the product is substantially pure glycolide.
The glycolide thus prepared is polymerized in the presence of an alcohol free of nonbenzenoid unsaturation and free of any reactive groups other than alcoholic hydroxy groups and in the presence of SnCl,-2H,O.
A heavy walled glass tube having a bore of about threetenth inch and sealed at one end is charged with 3 parts of the substantially pure glycolide composition, 0.04 part of a 0.l percent ether solution of SnCl,-2H,O (about 0.0013 percent of SnCl,-2H,O based on the weight of the substantially pure glycolide composition), 0.0166 part of lauryl alcohol (0.346 mole percent based on the moles of the substantially pure glycolide composition), and a magnetic steel ball five thirtysecond inch in diameter. The tube is evacuated and purged with argon. The tube is evacuated again to a vacuum of less than 1 mmsof Hg and the top is sealed. The reaction tube is placed in a vertical position in a closed glass chamber throughout which dimethyl phthalate is refluxed at 222 C. The boiling point of the dimethyl phthalate is controlled by decreasing the pressure of the system. At periodic intervals after melting, the viscosity of the reaction mixture is measured by raising the steel ball by means of a magnet and measuring the rate of the fall of the ball in sec./in. Ninety minutes after the melt is first achieved, the ball drop time is 550 sec./in. or about 7,200 poises, and after 120 minutes, the ball drop time is 580 sec./in. or about 7,600 poises.
The PGA thus produced is spun into 0.002-inch diameter fibers and used to form strands.
Additional PGA, similarly produced is used to form sheets, or tubes. These are wrapped around nerves, traumatically severed, to protect such nerves from invasive scar tissue growth, while the nerve is regenerating.
Also the PGA so produced is fabricated into the prosthetic devices shown in the drawings. The PGA may be moulded or machined or extruded to a desired configuration.
In FIG. I is shown an artery 37 which is joined together over a tapered end PGA tube 38 which fonns a stent about which the ends of the artery wall are joined by a suture splice 39. The tapered end is easier to insert in the artery.
In FIG. 2 the artery walls 40 are joined together over a flared end PGA tube 41 and the ends are joined by a suture splice 42.
FIG. 3 shows the flared end PGA tube 41.
In FIG. 4 is shown a blood vessel 43, the ends of which are each separatedly placed over the end of a flared PGA tube and which blood vessel is held in place with the ends adjacent to permit healing by a PGA spring clip 44. PGA, such as produced in the above example 3, shows an Izod impact strength of 0.14 ft.-lbs. per inch width or greater. It may be heated and fonned into a desired shape which shape is retained on cooling, and by shaping as a flat spring clip, can be used to hold together the walls of a blood vessel 43 until natural regeneration takes place.
In FIG. 5 is shown a similar splice of a blood vessel 45 but in which the ends are held together by an annular clip 46 of molded PGA. Such annular clips are well known for the attachment of radiator hoses to radiators in automobiles and the attachment of other flexible tubing to connectors. By a suitable choice of diameter and shape, as is well known in the industry, the radial compression at all points about the periphery may be caused to be approximately uniform and within a desired range. This is important in the splicing of blood vessels as it is desired to hold the blood vessel in position during regeneration, but yet not hold the vessels so tightly that necrosis sets in because of an impaired blood supply to the vessel walls.
While disclosed primarily for blood vessels, or vascular vessels, because jointure of such vessels is of greatest interest at present, obviously the same techniques and hollow splice cylinders can be used on any of a variety of vessels in the body of man or animals. Such tubes include fallopian tubes, spermatic ducts, bile ducts, ureters, sinus tubes, eustachian tubes, tear ducts, or for absorbable drain tubes in body cavities, or where a splice or joindure is required in any body tube. The size of the hollow cylinder is preferably such that the lumen, or internal diameter is about that of the tube being joined. The ends of the cylinder are conveniently tapered, so that the ends are readily insertable in the body tube, and for blood vessels so that a minimum of tubulence is induced in flowing blood, and hence thrombus formation is minimized. The PGA cylinder appears to be essentially nonthrombogenic.
The splice PGA cylinder normally is of uniform diameter, as usually the ends of the vessel to be spliced are the same. The diameters may be made different to join vessels of different sizes as may' occur where a splice is'to'be made between vessels not normally joined. T or Y-joints can be formed by molding or machining, with the various openings of a desired size, with the PGA protheses to be completely covered by the vessel walls. As the PGA protheses is absorbed, the vessel walls must grow together without defects.
Also because of the tremendous strength of the solid PGA, a surgical needle can be formed on the end of a PGA suture by either fusing the PGA of the suture, or molding additional PGA onto the suture end, the needle being bent and pointed as may be surgically preferred for a specific surgical procedure. The ends or edges of monocomponent or bicomponent fabrics containing PGA may be rendered rigid by moulding such edges, with or without additional solid PGA to a desired configuration. It is often easier to insert and retain a flexible fabric prosthetic tube if the end of the tube is of a size and shape to be inserted into the severed end of a vessel.
The drawings above are illustrative only of embodiment of the present invention in which various prosthetic devices are incorporated into the human body to aid impaired functions of natural elements. From the above drawings and descriptions, it will be obvious to those skilled in the art that many other modifications may be adapted for particular injuries or ills to which the flesh is heir.
The finding that polyglycolic acid, abbreviated PGA, is absorbable in living tissue, and has marked mechanical strength, as a fiber or solid, including sheet, and hence can be used as an element in, or as, a surgical prosthesis, is most unexpected and unpredictable.
Following the method set forth in the American Society for Testing and Materials, 1969 Books of Standards, Part 27, PlasticsGeneral Methods of Testing, Nomenclature, ASTM, 1916 Race St., Philadelphia, Pa. 19103, May 1969, procedure 709-66 at page 303 to 310, (procedure B); a flexure strength of about 40,000 pounds per square inch and a flexure modulus of 1.2 to l.4 l0 pounds per square inch is developed by the solid bars of PGA. For an unfilled plastic these values are spectacularly high. It is even more remarkable that such highstrength values are developed by a polymer that is absorbable by living mammalian tissue.
Catgut, or regenerated collagen has in the past been used for tissue emplacement, but with collagen, as the collagen is absorbed, a fibrotic tract replaces the collagen, so that in effect scar tissue remains at the site of the emplanted collagen for many years, in many instances for life. Some patients are allergic to collagen. PGA is not a protein, has no amino acids, and has given no evidence of allergic reactions in thousands of implants. With the present PGA prostheses, the PGA is completely absorbed, and a minimal or no trace of the inserted matter remains after a comparatively short period. This complete absorption, without residual fibrotic tissue, is unique, and an important contribution to surgery.
I. An absorbable prosthesis for the anastomosis of vessels in the tissue of a living mammal consisting essentially of a hollow cylinder of polyglycolic acid, having an inner diameter approximately the same as the inner diameter of the subject vessel, and a smooth outer surface of a diameter which is insertable in said vessel when stretched, whereby one end of a vessel from traumatic or surgical severance may be emplaced over each end of said cylinder, and fixedly positioned thereon, said cylinder being open to and permitting the flow of body fluids, and being absorbable by living mammalian tissue within a few weeks.
2. The absorbable prosthesis of claim I in cooperative eonfiguration with at least one circular cooperative clamp, whereby in assembled relationship, with a vascular vessel end on each end of said cylinder, the vascular vessel ends are uniformly positioned and retained on said cylinder, tightly enough to avoid substantial slippage, and loosely enough to permit circulation into the vessel ends, and hence avoid necro- SIS.
3. The absorbable prosthesis of claim 2 in which the said cooperative clamp is a single split ring, with inward tension sufficient to hold the ends of said vascular vessels, when positioned over said vessels in place over said hollow cylinder.
4. The absorbable prosthesis of claim 2 having two circularly bent rod clamps, said clamps having radii of curvature such that the vascular vessels are held against the hollow cylinder with approximately uniform pressure, around the periphery of said cylinder sufficiently tight to retain the vascular vessels during regeneration, but loosely enough to avoid necrosis.
5. A method of anastomizing two vessels in living mammalian tissue comprising inserting one end of a hollow cylinder of polyglycolic acid having an inner diameter of ap-
|Patente citada||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US2127903 *||5 May 1936||23 Ago 1938||Davis & Geck Inc||Tube for surgical purposes and method of preparing and using the same|
|US2428918 *||12 Sep 1944||14 Oct 1947||Grover C Miller||Anastomosis ring|
|US2676945 *||18 Oct 1950||27 Abr 1954||Du Pont||Condensation polymers of hydroxyacetic acid|
|US3155095 *||7 Feb 1961||3 Nov 1964||Brown Adolph M||Anastomosis method and means|
|US3297033 *||31 Oct 1963||10 Ene 1967||American Cyanamid Co||Surgical sutures|
|US3463158 *||9 Ene 1967||26 Ago 1969||American Cyanamid Co||Polyglycolic acid prosthetic devices|
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3883901 *||27 Nov 1973||20 May 1975||Rhone Poulenc Sa||Method of replacing or repairing the body with bioresorbable surgical articles|
|US4032993 *||25 Jun 1975||5 Jul 1977||Rhone-Poulenc Industries||Bioresorbable surgical articles|
|US4243775 *||13 Nov 1978||6 Ene 1981||American Cyanamid Company||Synthetic polyester surgical articles|
|US4275813 *||4 Jun 1979||30 Jun 1981||United States Surgical Corporation||Coherent surgical staple array|
|US4317451 *||19 Feb 1980||2 Mar 1982||Ethicon, Inc.||Plastic surgical staple|
|US4379138 *||28 Dic 1981||5 Abr 1983||Research Triangle Institute||Biodegradable polymers of lactones|
|US4443895 *||9 Jul 1982||24 Abr 1984||American Hospital Supply Corporation||Low-pressure fixation of valvular tissue intended for implantation|
|US4503568 *||25 Nov 1981||12 Mar 1985||New England Deaconess Hospital||Small diameter vascular bypass and method|
|US4523591 *||22 Oct 1982||18 Jun 1985||Kaplan Donald S||Polymers for injection molding of absorbable surgical devices|
|US4650488 *||16 May 1984||17 Mar 1987||Richards Medical Company||Biodegradable prosthetic device|
|US4670286 *||26 Dic 1985||2 Jun 1987||Allied Corporation||Method of forming prosthetic devices|
|US4674506 *||29 Nov 1984||23 Jun 1987||Kirk Alcond||Surgical anastomosis stent|
|US4744365 *||22 Sep 1987||17 May 1988||United States Surgical Corporation||Two-phase compositions for absorbable surgical devices|
|US4808351 *||25 Mar 1985||28 Feb 1989||American Cyanamid Company||Process for manufacturing a molded prosthetic device|
|US4841968 *||26 Sep 1986||27 Jun 1989||Southern Research Institute||Antithrombotic/thrombolytic suture and methods of making and using the same|
|US4863457 *||22 Abr 1988||5 Sep 1989||Lee David A||Drug delivery device|
|US4871365 *||24 Dic 1986||3 Oct 1989||American Cyanamid Company||Partially absorbable prosthetic tubular article having an external support|
|US4873977 *||11 Feb 1987||17 Oct 1989||Odis L. Avant||Stapling method and apparatus for vesicle-urethral re-anastomosis following retropubic prostatectomy and other tubular anastomosis|
|US4913903 *||10 Abr 1989||3 Abr 1990||Alza Corporation||Post-surgical applications for bioerodible polymers|
|US4997440 *||10 Ago 1990||5 Mar 1991||American Cyanamid Company||Vascular graft with absorbable and nonabsorbable components|
|US5124103 *||2 Ago 1990||23 Jun 1992||United States Surgical Corporation||Two phase compositions for absorbable surgical devices|
|US5160341 *||8 Nov 1990||3 Nov 1992||Advanced Surgical Intervention, Inc.||Resorbable urethral stent and apparatus for its insertion|
|US5180392 *||15 Nov 1990||19 Ene 1993||Einar Skeie||Anastomotic device|
|US5234006 *||18 Ene 1991||10 Ago 1993||Eaton Alexander M||Adjustable sutures and method of using the same|
|US5331975 *||2 Mar 1990||26 Jul 1994||Bonutti Peter M||Fluid operated retractors|
|US5354305 *||17 Dic 1992||11 Oct 1994||United States Surgical Corporation||Nerve repair device|
|US5403347 *||2 Mar 1994||4 Abr 1995||United States Surgical Corporation||Absorbable block copolymers and surgical articles fabricated therefrom|
|US5425739 *||17 Dic 1992||20 Jun 1995||Avatar Design And Development, Inc.||Anastomosis stent and stent selection system|
|US5431679 *||10 Mar 1994||11 Jul 1995||United States Surgical Corporation||Absorbable block copolymers and surgical articles fabricated therefrom|
|US5475063 *||14 Dic 1994||12 Dic 1995||United States Surgical Corporation||Blends of glycolide and/or lactide polymers and caprolactone and/or trimethylene carbonate polymers and absorbable surgical devices made|
|US5489297 *||2 Nov 1994||6 Feb 1996||Duran; Carlos M. G.||Bioprosthetic heart valve with absorbable stent|
|US5522841 *||29 Dic 1994||4 Jun 1996||United States Surgical Corporation||Absorbable block copolymers and surgical articles fabricated therefrom|
|US5527324 *||7 Sep 1994||18 Jun 1996||Krantz; Kermit E.||Surgical stent|
|US5542594 *||6 Oct 1993||6 Ago 1996||United States Surgical Corporation||Surgical stapling apparatus with biocompatible surgical fabric|
|US5551954 *||12 Oct 1994||3 Sep 1996||Scimed Life Systems, Inc.||Biodegradable drug delivery vascular stent|
|US5554170 *||26 Ene 1995||10 Sep 1996||United States Surgical Corporation||Absorbable block copolymers and surgical articles fabricated therefrom|
|US5607474 *||20 Sep 1993||4 Mar 1997||Board Of Regents, University Of Texas System||Multi-phase bioerodible implant/carrier and method of manufacturing and using same|
|US5618301 *||19 Ene 1996||8 Abr 1997||Angiomed Ag||Reducing stent, device with reducing stent and use of a reducing stent|
|US5618313 *||11 Oct 1994||8 Abr 1997||United States Surgical Corporation||Absorbable polymer and surgical articles fabricated therefrom|
|US5634946 *||7 Jun 1995||3 Jun 1997||Focal, Inc.||Polymeric endoluminal paving process|
|US5674287 *||14 Ene 1994||7 Oct 1997||Endoluminal Therapeutics, Inc.||Biodegradable polymeric endoluminal sealing process, apparatus and polymeric product for use therein|
|US5702656 *||7 Jun 1995||30 Dic 1997||United States Surgical Corporation||Process for making polymeric articles|
|US5749915 *||7 Jun 1995||12 May 1998||Focal, Inc.||Polymeric endoluminal paving process|
|US5749922 *||7 Jun 1995||12 May 1998||Endoluminal Therapeutics, Inc.||Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein|
|US5800538 *||7 Jun 1995||1 Sep 1998||Endoluminal Therapeutics, Inc.||Biodegradable polymeric endoluminal sealing process|
|US5876418 *||7 Abr 1997||2 Mar 1999||Angiomed Ag||Device for providing a duct in a living body|
|US5908427 *||30 May 1997||1 Jun 1999||United States Surgical Corporation||Surgical stapling apparatus and method|
|US5922022 *||31 Dic 1997||13 Jul 1999||Kensey Nash Corporation||Bifurcated connector system for coronary bypass grafts and methods of use|
|US5964774 *||12 Sep 1997||12 Oct 1999||United States Surgical Corporation||Surgical stapling apparatus and method with surgical fabric|
|US5997568 *||17 Ene 1997||7 Dic 1999||United States Surgical Corporation||Absorbable polymer blends and surgical articles fabricated therefrom|
|US6007565 *||5 Sep 1997||28 Dic 1999||United States Surgical||Absorbable block copolymers and surgical articles fabricated therefrom|
|US6013853 *||15 Feb 1994||11 Ene 2000||The University Of Texas System||Continuous release polymeric implant carrier|
|US6017352 *||16 Ene 1998||25 Ene 2000||Kensey Nash Corporation||Systems for intravascular procedures and methods of use|
|US6030395 *||28 May 1999||29 Feb 2000||Kensey Nash Corporation||Anastomosis connection system|
|US6036705 *||1 Jun 1999||14 Mar 2000||Kensey Nash Corporation||Anastomosis connection system and method of use|
|US6045560 *||17 Jun 1996||4 Abr 2000||United States Surgical Corporation||Surgical stapling apparatus with biocompatible surgical fabric|
|US6046251 *||18 Abr 1997||4 Abr 2000||Kureha Kagaku Kogyo K.K.||Injection-molded product of polyglycolic acid and production process thereof|
|US6056762 *||22 May 1997||2 May 2000||Kensey Nash Corporation||Anastomosis system and method of use|
|US6063114 *||4 Sep 1997||16 May 2000||Kensey Nash Corporation||Connector system for vessels, ducts, lumens or hollow organs and methods of use|
|US6136018 *||2 Ago 1999||24 Oct 2000||United States Surgical Corporation||Absorbable block copolymers and surgical articles fabricated therefrom|
|US6183679||15 Feb 2000||6 Feb 2001||Kureha Kagaku Kogyo, K.K.||Production process for injection-molded product of polyglycolic acid|
|US6191236||10 Oct 1997||20 Feb 2001||United States Surgical Corporation||Bioabsorbable suture and method of its manufacture|
|US6197050 *||14 Sep 1998||6 Mar 2001||Heartstent Corporation||Transmyocardial implant with compliance collar|
|US6206908||3 May 1999||27 Mar 2001||United States Surgical Corporation||Absorbable polymer and surgical articles fabricated therefrom|
|US6224626||1 Abr 1999||1 May 2001||Md3, Inc.||Ultra-thin expandable stent|
|US6228111||27 Sep 1996||8 May 2001||Bionx Implants Oy||Biodegradable implant manufactured of polymer-based material and a method for manufacturing the same|
|US6228954||1 Nov 1994||8 May 2001||United States Surgical Corporation||Blends of glycolide and/or lactide polymers and caprolactone and/or trimethylene carbonate polymers and absorabable surgical devices made therefrom|
|US6258122||5 Feb 1997||10 Jul 2001||St. Jude Medical, Inc.||Bioresorbable annuloplasty prosthesis|
|US6273897||29 Feb 2000||14 Ago 2001||Ethicon, Inc.||Surgical bettress and surgical stapling apparatus|
|US6277136||18 Feb 1999||21 Ago 2001||General Surgical Innovations, Inc.||Method for developing an anatomic space|
|US6277927||23 Nov 1998||21 Ago 2001||United States Surgical Corporation||Absorbable block copolymers and surgical articles fabricated therefrom|
|US6325810||30 Jun 1999||4 Dic 2001||Ethicon, Inc.||Foam buttress for stapling apparatus|
|US6350280||3 Feb 2000||26 Feb 2002||Kensey Nash Corporation||Surgical connector systems and methods of use|
|US6358266||9 Oct 1996||19 Mar 2002||General Surgical Innovations, Inc.||Active cannulas|
|US6402767||6 Mar 2000||11 Jun 2002||Kensey Nash Corporation||Anastomosis connection system and method of use|
|US6409750||1 Feb 2000||25 Jun 2002||Board Of Regents, The University Of Texas System||Woven bifurcated and trifurcated stents and methods for making the same|
|US6443941||24 Jul 2000||3 Sep 2002||Endoluminal Therapeutics, Inc.||Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein|
|US6524345||22 Oct 1997||25 Feb 2003||Bionx Implants Oy||Surgical implant|
|US6546188||13 Ene 1999||8 Abr 2003||Sony Corporation||Editing system and editing method|
|US6623521||14 Dic 2000||23 Sep 2003||Md3, Inc.||Expandable stent with sliding and locking radial elements|
|US6648911||20 Nov 2000||18 Nov 2003||Avantec Vascular Corporation||Method and device for the treatment of vulnerable tissue site|
|US6699272||13 Dic 2001||2 Mar 2004||Endoluminal Therapeutics, Inc.||Biodegradable polymeric endoluminal sealing process, apparatus and polymeric products for use therein|
|US6716932||25 Jul 2001||6 Abr 2004||Tyco Healthcare Group Lp||High consistency absorbable polymeric resin|
|US6792979||16 Sep 2002||21 Sep 2004||Board Of Regents, The University Of Texas System||Methods for creating woven devices|
|US6881766||7 Feb 2003||19 Abr 2005||Tyco Healthcare Group Lp||Sutures and coatings made from therapeutic absorbable glass|
|US6923820||19 Feb 2002||2 Ago 2005||Kensey Nash Corporation||Surgical connector systems and methods of use|
|US6926690||20 Sep 2001||9 Ago 2005||Percardia, Inc.||Transmyocardial shunt and its attachment mechanism, for left ventricular revascularization|
|US6953476||27 Mar 2000||11 Oct 2005||Neovasc Medical Ltd.||Device and method for treating ischemic heart disease|
|US7018401||1 Feb 2000||28 Mar 2006||Board Of Regents, The University Of Texas System||Woven intravascular devices and methods for making the same and apparatus for delivery of the same|
|US7048014||16 Sep 2002||23 May 2006||Board Of Regents, The University Of Texas System||Methods for creating woven devices|
|US7097907||30 Jul 2003||29 Ago 2006||United States Surgical Corporation||Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom|
|US7163557 *||16 Ene 2002||16 Ene 2007||D Eredita Riccardo||Biodegradable auricular prosthetic device|
|US7217273||5 Dic 2003||15 May 2007||General Surgical Innovations, Inc.||Fluid operated retractors|
|US7264624||11 Jul 2005||4 Sep 2007||Kensey Nash Corporation||Surgical connector systems and methods of use|
|US7311719||8 Abr 2003||25 Dic 2007||General Surgical Innovations, Inc.||Active cannulas|
|US7321008||28 Ago 2006||22 Ene 2008||United States Surgical Corporation||Bioabsorbable branched polymers end-capped with diketene acetals|
|US7695483||31 Ago 2007||13 Abr 2010||Kensey Nash Corporation||Surgical connector systems and methods of use|
|US7704275||26 Ene 2007||27 Abr 2010||Reva Medical, Inc.||Circumferentially nested expandable device|
|US7722662||13 Oct 2006||25 May 2010||Reva Medical, Inc.||Expandable stent with sliding and locking radial elements|
|US7763065||21 Jul 2004||27 Jul 2010||Reva Medical, Inc.||Balloon expandable crush-recoverable stent device|
|US7794490||22 Jun 2004||14 Sep 2010||Boston Scientific Scimed, Inc.||Implantable medical devices with antimicrobial and biodegradable matrices|
|US7833282 *||26 Feb 2007||16 Nov 2010||Mandpe Aditi H||Eustachian tube device and method|
|US7914574||2 Ago 2005||29 Mar 2011||Reva Medical, Inc.||Axially nested slide and lock expandable device|
|US7947071||9 Oct 2009||24 May 2011||Reva Medical, Inc.||Expandable slide and lock stent|
|US7988721||4 Dic 2007||2 Ago 2011||Reva Medical, Inc.||Axially-radially nested expandable device|
|US8172894||26 Abr 2010||8 May 2012||Reva Medical, Inc.||Circumferentially nested expandable device|
|US8192481||27 Ago 2010||5 Jun 2012||Boston Scientific Scimed, Inc.||Implantable medical devices with anti-microbial and biodegradable matrices|
|US8277500||20 Jun 2006||2 Oct 2012||Reva Medical, Inc.||Slide-and-lock stent|
|US8292944||17 Dic 2004||23 Oct 2012||Reva Medical, Inc.||Slide-and-lock stent|
|US8377080||13 Abr 2010||19 Feb 2013||Kensey Nash Corporation||Surgical connector systems and methods of use|
|US8388616 *||27 Feb 2006||5 Mar 2013||Endosmart Gesellschaft Für Medizintechnik MbH||Compression sleeve|
|US8414635||22 May 2008||9 Abr 2013||Idev Technologies, Inc.||Plain woven stents|
|US8419788||13 Jul 2012||16 Abr 2013||Idev Technologies, Inc.||Secured strand end devices|
|US8460363||29 Jul 2011||11 Jun 2013||Reva Medical, Inc.||Axially-radially nested expandable device|
|US8491612||17 Jun 2009||23 Jul 2013||Covidien Lp||Anastomosis sheath and method of use|
|US8506588||16 Sep 2009||13 Ago 2013||Toby Orthopaedics, Inc.||Suture retriever-sheath dilator tool and method for use thereof|
|US8512394||26 Jul 2010||20 Ago 2013||Reva Medical Inc.||Balloon expandable crush-recoverable stent device|
|US8523936||8 Abr 2011||3 Sep 2013||Reva Medical, Inc.||Expandable slide and lock stent|
|US8540762||7 May 2012||24 Sep 2013||Reva Medical, Inc.||Circumferentially nested expandable device|
|US8545547||23 May 2011||1 Oct 2013||Reva Medical Inc.||Expandable slide and lock stent|
|US8556954||21 Oct 2009||15 Oct 2013||Neovasc Medical Ltd||Methods for treating abnormal growths in the body using a flow reducing implant|
|US8617235||28 Mar 2011||31 Dic 2013||Reva Medical, Inc.||Axially nested slide and lock expandable device|
|US8679146||8 Dic 2011||25 Mar 2014||Toby Orthopaedics, Inc.||Method for use of suture retriever-sheath dilator tool|
|US8739382||13 Jul 2012||3 Jun 2014||Idev Technologies, Inc.||Secured strand end devices|
|US8747439||10 Jul 2006||10 Jun 2014||P Tech, Llc||Method of using ultrasonic vibration to secure body tissue with fastening element|
|US8808329||3 Abr 2012||19 Ago 2014||Bonutti Skeletal Innovations Llc||Apparatus and method for securing a portion of a body|
|US8814902||31 Jul 2006||26 Ago 2014||Bonutti Skeletal Innovations Llc||Method of securing body tissue|
|US8845687||17 Sep 2013||30 Sep 2014||Bonutti Skeletal Innovations Llc||Anchor for securing a suture|
|US8845699||6 Mar 2012||30 Sep 2014||Bonutti Skeletal Innovations Llc||Method of securing tissue|
|US8858612||13 Sep 2013||14 Oct 2014||Neovasc Medical Inc.||Methods for treating abnormal growths in the body using a flow reducing implant|
|US8876880||13 Jul 2012||4 Nov 2014||Board Of Regents, The University Of Texas System||Plain woven stents|
|US8876881||22 Oct 2007||4 Nov 2014||Idev Technologies, Inc.||Devices for stent advancement|
|US8900302||31 Ago 2012||2 Dic 2014||Toby Orthopaedics, Inc.||Tendon crimp for passage into a bone tunnel and method for use thereof|
|US8966733||28 May 2014||3 Mar 2015||Idev Technologies, Inc.||Secured strand end devices|
|US8974516||17 Dic 2013||10 Mar 2015||Board Of Regents, The University Of Texas System||Plain woven stents|
|US9023095||27 May 2011||5 May 2015||Idev Technologies, Inc.||Stent delivery system with pusher assembly|
|US9060772 *||17 Sep 2010||23 Jun 2015||Toby Orthopaedics, Inc.||Device for assisting in flexor tendon repair and rehabilitation|
|US9066827||4 Sep 2013||30 Jun 2015||Reva Medical, Inc.||Expandable slide and lock stent|
|US9149374||23 Abr 2014||6 Oct 2015||Idev Technologies, Inc.||Methods for manufacturing secured strand end devices|
|US9149378||18 Ago 2008||6 Oct 2015||Reva Medical, Inc.||Axially nested slide and lock expandable device|
|US9173751||13 Sep 2012||3 Nov 2015||Reva Medical, Inc.||Slide-and-lock stent|
|US9271734||14 May 2013||1 Mar 2016||Covidien Lp||Methods and devices for sheath compression|
|US9314354||10 May 2013||19 Abr 2016||Reva Medical, Inc.||Axially-radially nested expandable device|
|US9364354||3 Oct 2014||14 Jun 2016||Neovasc Medical Ltd||Methods for treating abnormal growths in the body using a flow reducing implant|
|US9402630||18 Jul 2013||2 Ago 2016||Covidien Lp||Anastomosis sheath and method of use|
|US9408729||20 Ene 2015||9 Ago 2016||Idev Technologies, Inc.||Secured strand end devices|
|US9408730||19 Ene 2016||9 Ago 2016||Idev Technologies, Inc.||Secured strand end devices|
|US9408732||11 Mar 2014||9 Ago 2016||Reva Medical, Inc.||Reduced-profile slide and lock stent|
|US9452068||28 Ago 2013||27 Sep 2016||Reva Medical, Inc.||Expandable slide and lock stent|
|US9585776||5 Ago 2016||7 Mar 2017||Idev Technologies, Inc.||Secured strand end devices|
|US20020052572 *||25 Sep 2001||2 May 2002||Kenneth Franco||Resorbable anastomosis stents and plugs and their use in patients|
|US20020103526 *||13 Dic 2001||1 Ago 2002||Tom Steinke||Protective coating for stent|
|US20030097172 *||27 Mar 2001||22 May 2003||Ilan Shalev||Narrowing implant|
|US20030199969 *||3 Jun 2003||23 Oct 2003||Steinke Thomas A.||Expandable stent with sliding and locking radial elements|
|US20040052992 *||15 Ago 2003||18 Mar 2004||Adele Boone||Biodegradeable shrink wrap|
|US20040058164 *||30 Jul 2003||25 Mar 2004||Bennett Steven L.||Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom|
|US20040097949 *||5 Dic 2003||20 May 2004||Bonutti Peter M.||Fluid operated retractors|
|US20040162580 *||7 Feb 2003||19 Ago 2004||Matthew Hain||Sutures and coatings made from therapeutic absorbable glass|
|US20040230288 *||17 Abr 2002||18 Nov 2004||Rosenthal Arthur L.||Medical devices adapted for controlled in vivo structural change after implantation|
|US20040249399 *||17 Jul 2002||9 Dic 2004||Phillippe Cinquin||Device for assembling blood vessels|
|US20050004584 *||4 May 2004||6 Ene 2005||Cohesion Technologies, Inc.||Resorbable anastomosis stents and plugs and their use in patients|
|US20050055082 *||3 Oct 2002||10 Mar 2005||Shmuel Ben Muvhar||Flow reducing implant|
|US20050075733 *||16 Ene 2002||7 Abr 2005||D'eredita Riccardo||Biodegradable auricular prosthetic device|
|US20050165428 *||25 Feb 2005||28 Jul 2005||Franco Kenneth L.||Absorable surgical structure|
|US20050245946 *||11 Jul 2005||3 Nov 2005||Nash John E||Surgical connector systems and methods of use|
|US20050267567 *||21 Jul 2005||1 Dic 2005||Neovasc Medical Ltd.||Device and method for treating ischemic heart disease|
|US20050283224 *||22 Jun 2004||22 Dic 2005||Scimed Life Systems, Inc.||Implantable medical devices with antimicrobial and biodegradable matrices|
|US20060009839 *||12 Jul 2004||12 Ene 2006||Scimed Life Systems, Inc.||Composite vascular graft including bioactive agent coating and biodegradable sheath|
|US20060014023 *||30 Jul 2003||19 Ene 2006||Bennett Steven L||Bioabsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom|
|US20060106449 *||7 Ago 2003||18 May 2006||Neovasc Medical Ltd.||Flow reducing implant|
|US20060106450 *||10 Abr 2003||18 May 2006||Neovasc Medical Ltd.||Geometric flow regulator|
|US20060149348 *||27 Feb 2006||6 Jul 2006||Bernd Vogel||Compression sleeve|
|US20060293406 *||28 Ago 2006||28 Dic 2006||Bennett Steven L|
|US20070043428 *||9 Mar 2006||22 Feb 2007||The University Of Tennessee Research Foundation||Barrier stent and use thereof|
|US20070233036 *||26 Feb 2007||4 Oct 2007||Aditi H Mandpe||Eustachian Tube Device and Method|
|US20070255422 *||25 Abr 2007||1 Nov 2007||Mei Wei||Calcium phosphate polymer composite and method|
|US20070293881 *||31 Ago 2007||20 Dic 2007||Nash John E||Surgical connector systems and methods of use|
|US20080051879 *||23 Ago 2007||28 Feb 2008||Cook Incorporated||Methods of treating venous valve related conditions with a flow-modifying implantable medical device|
|US20080103519 *||14 Dic 2007||1 May 2008||Bonutti Peter M||Active cannulas|
|US20080215076 *||7 May 2008||4 Sep 2008||Sentinel Group, Llc||Gastro-intestinal therapeutic device and method|
|US20100010517 *||17 Jun 2009||14 Ene 2010||Joshua Stopek||Anastomosis Sheath And Method Of Use|
|US20100010518 *||17 Jun 2009||14 Ene 2010||Joshua Stopek||Anastomosis Sheath And Method Of Use|
|US20100010519 *||17 Jun 2009||14 Ene 2010||Joshua Stopek||Anastomosis Sheath And Method Of Use|
|US20100114299 *||21 Oct 2009||6 May 2010||Neovasc Medical Ltd.||Flow reducing implant|
|US20100137883 *||16 Sep 2009||3 Jun 2010||Toby Orthopaedics, Llc||Suture retriever-sheath dilator tool and method for use thereof|
|US20100217290 *||13 Abr 2010||26 Ago 2010||Nash John E||Surgical connector systems and methods of use|
|US20100324667 *||27 Ago 2010||23 Dic 2010||Boston Scientific Scimed, Inc.||Implantable medical devices with anti-microbial and biodegradable matrices|
|US20110015656 *||17 Sep 2010||20 Ene 2011||Eduardo Gonzalez-Hernandez||Device for assisting in flexor tendon repair and rehabilitation|
|EP0158316A2 *||9 Abr 1985||16 Oct 1985||Walsh Manufacturing (Mississauga) Limited||Anastomosis devices and kit|
|EP0158316A3 *||9 Abr 1985||26 Feb 1986||Walsh Manufacturing (Mississauga) Limited||Anastomosis devices and kit|
|EP0199074A1 *||17 Mar 1986||29 Oct 1986||American Cyanamid Company||Process for manufacturing an annealed prosthetic device|
|EP0282157A1 *||2 Feb 1988||14 Sep 1988||AVANT, Odis Lynn||Stapling apparatus for anastomosis, in particular for urethra-bladder anastomosis|
|EP0336148A2 *||14 Mar 1989||11 Oct 1989||Beiersdorf Aktiengesellschaft||Surgical implants|
|EP0480293A1 *||1 Oct 1991||15 Abr 1992||LaserSurge, Inc.||Clamp for approximating tissue sections|
|EP0701823A2||18 Sep 1995||20 Mar 1996||United States Surgical Corporation||Absorbable polymer and surgical articles fabricated therefrom|
|EP0786259A2||17 Ene 1997||30 Jul 1997||United States Surgical Corporation||Absorbable polymer blends and surgical articles fabricated therefrom|
|EP2036582A1||21 Jul 1995||18 Mar 2009||United States Surgical Corporation||Biobsorbable branched polymers containing units derived from dioxanone and medical/surgical devices manufactured therefrom|
|EP2301597A1||21 Jul 1995||30 Mar 2011||United States Surgical Corporation|
|WO1987004915A1 *||18 Feb 1987||27 Ago 1987||Ekkehard Euler||Device for the macro- and microsurgical junction of vessel ends|
|WO1994013356A1 *||7 Dic 1993||23 Jun 1994||Avatar Design And Development, Inc.||Anastomosis stent and stent selection system|
|WO1997016135A1 *||1 Nov 1996||9 May 1997||St. Jude Medical, Inc.||Bioresorbable annuloplasty prosthesis|
|WO1998018408A1||22 Oct 1997||7 May 1998||Bionix Implants Oy||Surgical implant|
|WO1999033403A1||19 Nov 1998||8 Jul 1999||Kensey Nash Corporation||Bifurcated connector system for coronary bypass grafts|
|WO2004089248A2 *||31 Mar 2004||21 Oct 2004||Giler Ltd.||Stent for use in mammalian anastomosis and method and system for implanting said stent|
|WO2004089248A3 *||31 Mar 2004||18 Nov 2004||Nachum Erlich||Stent for use in mammalian anastomosis and method and system for implanting said stent|
|Clasificación de EE.UU.||606/154, 623/1.1, 606/155|
|Clasificación internacional||A61B17/11, D01F6/62, A61F13/15, A61L31/06, A61F13/00, A61B17/00, A61F13/20|
|Clasificación cooperativa||A61F2013/00157, A61F13/551, A61L31/06, D01F6/625, A61B2017/00004, A61B17/11, A61F13/20, A61F2013/00221|
|Clasificación europea||A61L31/06, D01F6/62B, A61B17/11|